Bio-Rad Laboratories Profit Margin

Bio-Rad Laboratories's profit margin stands at 8.59% as of June 2026. That compares with 9.99% in the prior-year period — down 14.0% year over year. That is below the Healthcare sector average of 14.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bio-Rad Laboratories reported 8.59% in profit margin versus 9.99% a year earlier — a 14.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Bio-Rad Laboratories sits lower the Healthcare benchmark (14.34%) with a profit margin of 8.59%. That is roughly 40.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 8.59% for Bio-Rad Laboratories means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Bio-Rad Laboratories's profit margin evolved across reporting periods, while the comparison chart places BIO.B next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.